-
Tuberculosis incidence in foreign-born people residing in European countries in 2020
- Anca Vasiliu1,* , Niklas Köhler2,3,4,* , Ekkehardt Altpeter5 , Tinna Rán Ægisdóttir6 , Marina Amerali7 , Wouter Arrazola de Oñate8,9 , Ágnes Bakos10 , Stefania D’Amato11 , Daniela Maria Cirillo12 , Reinout van Crevel13,14 , Edita Davidaviciene15 , Irène Demuth16 , Jose Domínguez17 , Raquel Duarte18,19,20 , Gunar Günther21,22 , Jean-Paul Guthmann23 , Sophia Hatzianastasiou7 , Louise Hedevang Holm24 , Zaida Herrador25 , Urška Hribar26 , Conny Huberty16 , Elmira Ibraim27 , Sarah Jackson28 , Mogens Jensenius29 , Kamilla Sigridur Josefsdottir30 , Anders Koch24,31 , Maria Korzeniewska-Kosela32 , Liga Kuksa33 , Heinke Kunst34 , Christian Lienhardt35,36 , Beatrice Mahler27,37 , Mateja Janković Makek38,39 , Inge Muylle40 , Johan Normark41,42 , Analita Pace-Asciak43 , Goranka Petrović44 , Despo Pieridou45 , Giulia Russo12 , Olena Rzhepishevska46 , Helmut J.F. Salzer47,48 , Marta Sá Marques20 , Daniela Schmid49 , Ivan Solovic50,51 , Mariya Sukholytka52 , Petra Svetina53 , Mariya Tyufekchieva54 , Tuula Vasankari55,56 , Piret Viiklepp57 , Kersti Villand57 , Jiri Wallenfels58 , Stefan Wesolowski32 , Anna-Maria Mandalakas1,2 , Leonardo Martinez59 , Dominik Zenner60,61 , Christoph Lange1,2,3,4 , on behalf of the TBnet62
-
View Affiliations Hide AffiliationsAffiliations: 1 Baylor College of Medicine, Department of Pediatrics, Global and Immigrant Health, Global Tuberculosis Program, Houston, Texas, United States 2 Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany 3 German Center for Infection Research (DZIF), TTU-TB, Borstel, Germany 4 Respiratory Medicine & International Health, University of Lübeck, Lübeck, Germany 5 Swiss Federal Office of Public Health, Division of Communicable Diseases, Bern, Switzerland 6 The National University Hospital of Iceland, Pharmaceutical Services, Reykjavik, Iceland 7 Tuberculosis Control Office, Department of Respiratory Infections, Directorate for Epidemiological Surveillance & Intervention, National Public Health Organization (NPHO), Athens, Greece 8 Belgian Lung and Tuberculosis Association, Brussels, Belgium 9 Flemish Association of Respiratory Health and TB Control, Leuven, Belgium 10 Koranyi National Institute for Pulmonology, Budapest, Hungary 11 Prevention of Communicable Diseases and International Prophylaxis, General Direction of Health Prevention, Ministry of Health of Italy, Rome, Italy 12 Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy 13 Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands 14 Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom 15 Vilnius University hospital Santaros Klinikos, Department of Tuberculosis State information system, Vilnius, Lithuania 16 Health Directorate of Luxembourg, Luxembourg 17 Institut d’Investigació Germans Trias i Pujol; Universitat Autònoma de Barcelona; CIBER Enfermedades Respiratorias; INNOVA4TB consortium Badalona, Barcelona, Spain 18 ICBAS – Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto 19 ISPUP – Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal 20 Centro Hospitalar de Vila Nova de Gaia/Espinho, Porto, Portugal 21 Department of Pulmonary Medicine and Allergology, Inselspital, Bern University Hospital, University of Bern, Switzerland 22 Department of Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia 23 Division of Infectious Diseases, Santé publique France, Saint-Maurice, France 24 Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark 25 Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain 26 Tuberculosis Register of the Republic of Slovenia, University Clinic Golnik, Golnik, Slovenia 27 Marius Nasta Institute of Pulmonology, Bucharest, Romania 28 Infectious Diseases; Health Service Executive Health Protection Surveillance Centre, Dublin, Ireland 29 Department of Infectious Diseases, Oslo University Hospital, Ullevaal, Norway 30 Centre for Health Security and Communicable Disease Control, Directorate of Health, Iceland 31 Department of Infectious Diseases, Rigshospitalet University Hospital, Copenhagen, Denmark 32 Department of Tuberculosis Epidemiology and Surveillance, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland 33 Riga East University Hospital, TB and Lung Disease Clinic, Riga, Latvia 34 Blizard Institute, The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom 35 Unité Unité Mixte Internationale 233 IRD – U1175 INSERM - Université de Montpellier, Institut de Recherche pour le Développement (IRD), Montpellier, France 36 Epidemiology and Population Health, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom 37 Department Cardio-thoracic, Pneumophtisiology II, University of Medicine and Pharmacy “Carol Davila” Bucharest, Romania 38 University of Zagreb, School of Medicine Zagreb, Croatia 39 University Hospital Centre Zagreb, Department for Lung diseases, Zagreb, Croatia 40 Division of Pneumology, Onze-Lieve-Vrouw Ziekenhuis (OLV) Aalst, Aalst, Belgium 41 Department of Clinical Microbiology, Umeå University, Sweden 42 Wallenberg Centre for Molecular Medicine, Umeå University, Sweden 43 Infectious Disease Prevention and Control Unit, Health Promotion and Disease Prevention Directorate, Superintendence of Public Health, Ministry for Health of Malta, La Valetta, Malta 44 Respiratory Diseases and Travel Medicine Department with Vaccination Unit, Infectious Diseases Epidemiology ServiceDepartment, Croatian Institute of Public Health, Zagreb, Croatia 45 Cyprus National Reference Laboratory for Mycobacteria, Microbiology Department, Nicosia General Hospital, Nicosia, Cyprus 46 Department of Chemistry, Department of Clinical Microbiology, Umeå University, Sweden 47 Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine 4- Pneumology, Kepler University Hospital, Linz, Austria 48 Faculty of Medicine, Johannes-Kepler-University, Linz, Austria and Ignaz Semmelweis Institut, Interuniversity Institute for Infection Resarch, Vienna, Austria 49 Unit for Infectious Diseases Diagnostics and Infectious Diseases Epidemiology, Centre for Pathophysiology, Infectious Diseases and Immunology, Medical University of Vienna, Vienna, Austria 50 National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Slovakia 51 Catholic University Ruzomberok, Ruzomberok, Slovakia 52 First Faculty of Medicine and Faculty Thomayer Hospital Prague, Czechia 53 National TB Program and Tuberculosis Registry of Republic of Slovenia, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia 54 Health Promotion and Prevention Unit, Directorate Public Health Protection and Health Control, Ministry of Health of Bulgaria, Sofia, Bulgaria 55 University of Turku, Division of Medicine, Department of Pulmonary Diseases and Clinical Allergology, Turku, Finland 56 Finnish Lung Health Association (Filha ry), Helsinki, Finland 57 Estonian Tuberculosis Register, Dept. of Registries, National Institute for Health Development, Tallinn, Estonia 58 National TB Surveillance Unit, University Hospital Bulovka, Prague, Czechia 59 Boston University, School of Public Health, Department of Epidemiology, Boston, Massachusetts, United States 60 Global Public Health Unit, Wolfson Institute of Population Health Barts 61 The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom 62 The Tuberculosis Network European Trials Group (TBNET) (www.tbnet.eu)* These authors contributed equally to this work and share first authorship.Correspondence:Christoph Langeclange fz-borstel.de
-
View Citation Hide Citation
Citation style for this article: Vasiliu Anca, Köhler Niklas, Altpeter Ekkehardt, Ægisdóttir Tinna Rán, Amerali Marina, de Oñate Wouter Arrazola, Bakos Ágnes, D’Amato Stefania, Cirillo Daniela Maria, van Crevel Reinout, Davidaviciene Edita, Demuth Irène, Domínguez Jose, Duarte Raquel, Günther Gunar, Guthmann Jean-Paul, Hatzianastasiou Sophia, Holm Louise Hedevang, Herrador Zaida, Hribar Urška, Huberty Conny, Ibraim Elmira, Jackson Sarah, Jensenius Mogens, Josefsdottir Kamilla Sigridur, Koch Anders, Korzeniewska-Kosela Maria, Kuksa Liga, Kunst Heinke, Lienhardt Christian, Mahler Beatrice, Makek Mateja Janković, Muylle Inge, Normark Johan, Pace-Asciak Analita, Petrović Goranka, Pieridou Despo, Russo Giulia, Rzhepishevska Olena, Salzer Helmut J.F., Marques Marta Sá, Schmid Daniela, Solovic Ivan, Sukholytka Mariya, Svetina Petra, Tyufekchieva Mariya, Vasankari Tuula, Viiklepp Piret, Villand Kersti, Wallenfels Jiri, Wesolowski Stefan, Mandalakas Anna-Maria, Martinez Leonardo, Zenner Dominik, Lange Christoph, on behalf of the TBnet. Tuberculosis incidence in foreign-born people residing in European countries in 2020. Euro Surveill. 2023;28(42):pii=2300051. https://doi.org/10.2807/1560-7917.ES.2023.28.42.2300051 Received: 24 Jan 2023; Accepted: 12 May 2023
Abstract
European-specific policies for tuberculosis (TB) elimination require identification of key populations that benefit from TB screening.
We aimed to identify groups of foreign-born individuals residing in European countries that benefit most from targeted TB prevention screening.
The Tuberculosis Network European Trials group collected, by cross-sectional survey, numbers of foreign-born TB patients residing in European Union (EU) countries, Iceland, Norway, Switzerland and the United Kingdom (UK) in 2020 from the 10 highest ranked countries of origin in terms of TB cases in each country of residence. Tuberculosis incidence rates (IRs) in countries of residence were compared with countries of origin.
Data on 9,116 foreign-born TB patients in 30 countries of residence were collected. Main countries of origin were Eritrea, India, Pakistan, Morocco, Romania and Somalia. Tuberculosis IRs were highest in patients of Eritrean and Somali origin in Greece and Malta (both > 1,000/100,000) and lowest among Ukrainian patients in Poland (3.6/100,000). They were mainly lower in countries of residence than countries of origin. However, IRs among Eritreans and Somalis in Greece and Malta were five times higher than in Eritrea and Somalia. Similarly, IRs among Eritreans in Germany, the Netherlands and the UK were four times higher than in Eritrea.
Country of origin TB IR is an insufficient indicator when targeting foreign-born populations for active case finding or TB prevention policies in the countries covered here. Elimination strategies should be informed by regularly collected country-specific data to address rapidly changing epidemiology and associated risks.
Article metrics loading...
Full text loading...
References
-
Koch R. Die Aetiologie der Tuberkulose.[The etiology of tuberculosis]. Berl Klin Wschr.1882;15:221-30. German.
-
McAuliffe M, Triandafyllidou A. World Migration Report 2022. Geneva: International Organization for Migration (IOM); 2021. Available from: https://publications.iom.int/books/world-migration-report-2022
-
Dhavan P, Dias HM, Creswell J, Weil D. An overview of tuberculosis and migration. Int J Tuberc Lung Dis. 2017;21(6):610-23. https://doi.org/10.5588/ijtld.16.0917 PMID: 28482955
-
European Centre for Disease Prevention and Control (ECDC), and World Health Organization Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2022 – 2020 data. Copenhagen: WHO Regional Office for Europe and Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/en/publications-data/tuberculosis-surveillance-and-monitoring-europe-2022-2020-data
-
World Health Organization (WHO). Global Tuberculosis Report. Geneva: WHO; 2021. Available from: https://www.who.int/publications/i/item/9789240037021
-
Lönnroth K, Raviglione M. The WHO’s new End TB Strategy in the post-2015 era of the Sustainable Development Goals. Trans R Soc Trop Med Hyg. 2016;110(3):148-50. https://doi.org/10.1093/trstmh/trv108 PMID: 26884490
-
Hollo V, Beauté J, Ködmön C, van der Werf MJ. Tuberculosis notification rate decreases faster in residents of native origin than in residents of foreign origin in the EU/EEA, 2010 to 2015. Euro Surveill. 2017;22(12):30486. https://doi.org/10.2807/1560-7917.ES.2017.22.12.30486 PMID: 28367798
-
Lönnroth K, Mor Z, Erkens C, Bruchfeld J, Nathavitharana RR, van der Werf MJ, et al. Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points. Int J Tuberc Lung Dis. 2017;21(6):624-37. https://doi.org/10.5588/ijtld.16.0845 PMID: 28482956
-
Matteelli A, Rendon A, Tiberi S, Al-Abri S, Voniatis C, Carvalho ACC, et al. Tuberculosis elimination: where are we now? Eur Respir Rev. 2018;27(148):180035. . Available from: https://err.ersjournals.com/content/27/148/180035 https://doi.org/10.1183/16000617.0035-2018 PMID: 29898905
-
Styblo K. The elimination of tuberculosis in The Netherlands. Bull Int Union Tuberc Lung Dis. 1990;65(2-3):49-55. PMID: 2257359
-
D’Ambrosio L, Dara M, Tadolini M, Centis R, Sotgiu G, van der Werf MJ, et al. , European national programme representatives. Tuberculosis elimination: theory and practice in Europe. Eur Respir J. 2014;43(5):1410-20. https://doi.org/10.1183/09031936.00198813 PMID: 24389868
-
European Centre for Disease Prevention and Control (ECDC). Programmatic management of latent tuberculosis infection in the European Union. Stockholm: ECDC; 2018. Available from: https://www.ecdc.europa.eu/en/publications-data/programmatic-management-latent-tuberculosis-infection-european-union
-
Lorenz M, Aisch G, Kokkelink D. Datawrapper. Enrich your stories with charts, maps, and tables. [Accessed: 19 Sep 2023]. Available from: https://www.datawrapper.de/
-
SankeyMATIC. Make beautiful flow diagrams. [Accessed: 1 Aug 2022]. Available from: https://sankeymatic.com/
-
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-7. https://doi.org/10.1016/S0140-6736(07)61602-X PMID: 18064739
-
World Health Organization (WHO). Tuberculosis prevention and care among refugees and other populations in humanitarian settings: an interagency field guide. Geneva: WHO; 2 Mar 2022. Available from: https://www.who.int/publications/i/item/9789240042087
-
Ködmön C, Zucs P, van der Werf MJ. Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013. Euro Surveill. 2016;21(12):30164. https://doi.org/10.2807/1560-7917.ES.2016.21.12.30164 PMID: 27039665
-
Dale KD, Trauer JM, Dodd PJ, Houben RMGJ, Denholm JT. Estimating Long-term Tuberculosis Reactivation Rates in Australian Migrants. Clin Infect Dis. 2020;70(10):2111-8. https://doi.org/10.1093/cid/ciz569 PMID: 31246254
-
van den Boogaard J, Slump E, Schimmel HJ, van der Hoek W, van den Hof S, de Vries G. High Incidence of Active Tuberculosis in Asylum Seekers from Eritrea and Somalia in the First 5 Years after Arrival in the Netherlands. Emerg Infect Dis. 2020;26(4):675-81. https://doi.org/10.3201/eid2604.190123 PMID: 32186488
-
Dale KD, Karmakar M, Snow KJ, Menzies D, Trauer JM, Denholm JT. Quantifying the rates of late reactivation tuberculosis: a systematic review. Lancet Infect Dis. 2021;21(10):e303-17. https://doi.org/10.1016/S1473-3099(20)30728-3 PMID: 33891908
-
Swedish Parliament. Lag (2008:344) om hälso- och sjukvård åt asylsökande m.fl. [Act (2008:344) on healthcare for asylum seekers and others]. Stockholm: Swedish Parliament. [Accessed 3 Oct 2023]. Swedish. Available from: https://www.riksdagen.se/sv/dokument-och-lagar/dokument/svensk-forfattningssamling/lag-2008344-om-halso-och-sjukvard-at_sfs-2008-344/
-
Wild V, Jaff D, Shah NS, Frick M. Tuberculosis, human rights and ethics considerations along the route of a highly vulnerable migrant from sub-Saharan Africa to Europe. Int J Tuberc Lung Dis. 2017;21(10):1075-85. https://doi.org/10.5588/ijtld.17.0324 PMID: 28911349
-
Walker TM, Merker M, Knoblauch AM, Helbling P, Schoch OD, van der Werf MJ, et al. , MDR-TB Cluster Consortium. A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study. Lancet Infect Dis. 2018;18(4):431-40. https://doi.org/10.1016/S1473-3099(18)30004-5 PMID: 29326013
-
Heuvelings CC, de Vries SG, Grobusch MP. Tackling TB in low-incidence countries: improving diagnosis and management in vulnerable populations. Int J Infect Dis. 2017;56:77-80. https://doi.org/10.1016/j.ijid.2016.12.025 PMID: 28062228
-
Arrazola de Oñate W, Weber L, Janssens K, Wanlin M, Forier A, Schol S, et al. Tuberculosis screening yield of asylum seekers in Europe. Eur Respir J. 2016;48(4):1253-4. https://doi.org/10.1183/13993003.00991-2016 PMID: 27694419
-
Bozorgmehr K, Preussler S, Wagner U, Joggerst B, Szecsenyi J, Razum O, et al. Using country of origin to inform targeted tuberculosis screening in asylum seekers: a modelling study of screening data in a German federal state, 2002-2015. BMC Infect Dis. 2019;19(1):304. https://doi.org/10.1186/s12879-019-3902-x PMID: 30943917
-
Heldal E, Kuyvenhoven JV, Wares F, Migliori GB, Ditiu L, Fernandez de la Hoz K, et al. Diagnosis and treatment of tuberculosis in undocumented migrants in low- or intermediate-incidence countries. Int J Tuberc Lung Dis. 2008;12(8):878-88. PMID: 18647446
Data & Media loading...
Supplementary data
-
-
Supplementary Material
-